Multisystemic inflammatory syndrome post-COVID-19: A new emerging entity

Authors

  • Vijay B Sonawane
  • Veeranna Kotrashetti
  • Kapil Bainade
  • V Trisha
  • Saili Bunde
  • Saniya Sroa

DOI:

https://doi.org/10.32677/IJCR.2021.v07.i06.011

Keywords:

Multisystem inflammatory syndrome, Pediatric inflammatory multisystem syndrome, Post-COVID

Abstract

Multisystem inflammatory syndrome in children (MISC-C), also known as the pediatric inflammatory multisystem syndrome, is a new dangerous childhood disease that may be associated with COVID disease. Signs and symptoms depend on the body part involved. We report a case of complicated post-COVID MIS-C in a 5-year-old child who presented with fever, vomiting, pain abdomen for 6 days, and rash for 2 days. Since the patient had complaints of high-grade fever for more than 5 days, rash, non-purulent conjunctivitis, cracked lips with cardiac and respiratory, and gastrointestinal involvement with positive COVID antibodies, and raised CRP; she was diagnosed to have the MIS-C post-COVID. The patient was started on oral aspirin and oral prednisolone for 2 weeks and discharged with proper advice.

Downloads

Download data is not yet available.

Downloads

Published

2021-06-28

Issue

Section

Case Report

How to Cite

Multisystemic inflammatory syndrome post-COVID-19: A new emerging entity. (2021). Indian Journal of Case Reports, 7(6), 254-256. https://doi.org/10.32677/IJCR.2021.v07.i06.011

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 > >>